Continuous perioperative apomorphine in deep brain stimulation surgery for Parkinson's disease

References

• Venkatraghavan L, Manninen P. Anesthesia for deep brain stimulation. Curr Opin Anaesthesiol 2011;24:495–9.
   PubMedGoogle Scholar
• Dagtekin O, Berlet T, Gerbershagen HJ, Dueck M, Giesecke T. Anesthesia and deep brain stimulation: postoperative akinetic state after replacement of impulse generators. Anesth Analg 2006;103:784.
   PubMedGoogle Scholar
• Poon CC, Irwin MG. Anaesthesia for deep brain stimulation and in patients with implanted neurostimulator devices. Br J Anaesth 2009;103:152–65.
   PubMed Web of Science ®Google Scholar
• Ramaiah VK, Newman V. Deep brain stimulation and surgery. Anaesthesia 2009;64:451–2.
   PubMedGoogle Scholar
• Thomas A, Iacono D, Luciano AL, Armellino K, Onofrj M. Acute akinesia or akinetic crisis in Parkinson's disease. Neurol Sci 2003;24:219–20.
   PubMedGoogle Scholar
• Venkatraghavan L, Manninen P, Mak P, et al. Anesthesia for functional neurosurgery: review of complications. J Neurosurg Anesthesiol 2006;18:64–7.
   PubMedGoogle Scholar
• Antonini A, Isaias IU, Rodolfi G, et al. A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation. J Neurol 2011;258:579–5.
   PubMed Web of Science ®Google Scholar
• Dewey RB Jr. 10 questions about using apomorphine for Parkinson disease. Neurologist 2005;11:190–2.
   PubMedGoogle Scholar
• Gunzler SA. Apomorphine in the treatment of Parkinson disease and other movement disorders. Expert Opin Pharmacother 2009;10:1027–38.
   PubMed Web of Science ®Google Scholar
• Frankel JP, Lees AJ, Kempster PA, Stern GM. Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry 1990;53:96–101.
   PubMed Web of Science ®Google Scholar
• Kempster PA, Frankel JP, Stern GM, Lees AJ. Comparison of motor response to apomorphine and levodopa in Parkinson's disease. J Neurol Neurosurg Psychiatry 1990;53:1004–7.
   PubMed Web of Science ®Google Scholar
• Merello M, Leiguarda R. [Treatment of motor fluctuations in Parkinson's disease with subcutaneous injections of apomorphine]. Medicina 1995;55:5–10.
   PubMedGoogle Scholar
• Pietz K, Hagell P, Odin P. Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up. J Neurol Neurosurg Psychiatry 1998;65:709–16.
   PubMed Web of Science ®Google Scholar
• Steiger MJ, Quinn NP, Marsden CD. The clinical use of apomorphine in Parkinson's disease. J Neurol 1992;239:389–93.
   PubMedGoogle Scholar
• Gancher ST, Woodward WR, Boucher B, Nutt JG. Peripheral pharmacokinetics of apomorphine in humans. Ann Neurol 1989;26:232–8.
   PubMed Web of Science ®Google Scholar
• Galvez-Jimenez N, Lang AE. Perioperative problems in Parkinson's disease and their management: apomorphine with rectal domperidone. Can J Neurol Sci 1996;23:198–203.
   PubMed Web of Science ®Google Scholar
• Agid Y, Barroche G, Bonnet AM, et al. Dopamine receptor stimulating agonists in the treatment of Parkinson's disease. Biomedicine 1979;30:67–71.
   PubMedGoogle Scholar
• Corsini GU, Del Zompo M, Gessa GL, Mangoni A (1979). Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson's disease. Lancet 1:954–956.
   PubMed Web of Science ®Google Scholar
• Chan DT, Zhu XL, Yeung JH, et al. Complications of deep brain stimulation: a collective review. Asian J Surg 2009;32: 258–63.
   PubMed Web of Science ®Google Scholar
• Hu X, Jiang X, Zhou X, et al. Avoidance and management of surgical and hardware-related complications of deep brain stimulation. Stereotact Funct Neurosurg 2010;88:296–303.
   PubMed Web of Science ®Google Scholar
• Krishnan SS, Evans A, Kaye AH. Unresponsiveness due to a post surgical Parkinsonian crisis. J Clin Neurosci 2010;17: 930–1.
   PubMedGoogle Scholar
• Vergani F, Landi A, Pirillo D, et al. Surgical, medical, and hardware adverse events in a series of 141 patients undergoing subthalamic deep brain stimulation for Parkinson disease. World Neurosurg 2010;73:338–44.
   PubMedGoogle Scholar
• Chou YC, Lin SZ, Hsieh WA, et al. Surgical and hardware complications in subthalamic nucleus deep brain stimulation. J Clin Neurosci 2007;14:643–9.
   PubMed Web of Science ®Google Scholar
• Okun MS, Rodriguez RL, Foote KD, et al. A case-based review of troubleshooting deep brain stimulator issues in movement and neuropsychiatric disorders. Parkinsonism Relat Disord 2008;14:532–8.
   PubMedGoogle Scholar
• Venkatraghavan L, Luciano M, Manninen P. Review article: anesthetic management of patients undergoing deep brain stimulator insertion. Anesth Anal 2010;110:1138–45.
   PubMed Web of Science ®Google Scholar
• Morishita T, Foote KD, Burdick AP, et al. Identification and management of deep brain stimulation intra- and postoperative urgencies and emergencies. Parkinsonism Relat Disord 2010;16:153–62.
   PubMed Web of Science ®Google Scholar
• Seijo FJ, Alvarez-Vega MA, Gutierrez JC, Fdez-Glez F, Lozano B. Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson's disease. Review of 272 procedures. Acta neurochir 2007;149:867–875; discussion 876.
   PubMed Web of Science ®Google Scholar
• Khatib R, Ebrahim Z, Rezai A, et al. Perioperative events during deep brain stimulation: the experience at cleveland clinic. J Neurosurg Anesthesiol 2008;20:36–40.
   PubMedGoogle Scholar
• Mikos A, Pavon J, Bowers D, et al. Factors related to extended hospital stays following deep brain stimulation for Parkinson's disease. Parkinsonism Relat Disord 2010;16:324–8.
   PubMedGoogle Scholar
• Mann JM, Foote KD, Garvan CW, et al. Brain penetration effects of microelectrodes and DBS leads in STN or GPi. J Neurol Neurosurg Psychiatry 2009;80:794–7.
   PubMed Web of Science ®Google Scholar
• Acland KM, Churchyard A, Fletcher CL, et al. Panniculitis in association with apomorphine infusion. Br J Dermatol 1998; 138:480–2.
   PubMedGoogle Scholar
• Chou KL, Siderowf AD, Jaggi JL, Liang GS, Baltuch GH. Unilateral battery depletion in Parkinson's disease patients treated with bilateral subthalamic nucleus deep brain stimulation may require urgent surgical replacement. Stereotact Funct Neurosurg 2004;82: 153–5.
   PubMedGoogle Scholar